Asset information about Argenx SE (ARGNF)
Stock | ISIN: NL0010832176 | WKN: A11602
Key Statistics
About Argenx SE
Argenx SE is a biotechnology company that specializes in the development of antibody-based therapies for the treatment of severe autoimmune diseases and cancer. The company uses its innovative antibody technologies to create targeted drugs that offer patients a better quality of life. Argenx SE is based in the Netherlands but operates globally.
What many investors track for Argenx SE
- Catch strong price moves faster (e.g., with a multi-day delta alert).
- Track trend zones: distance to the 50/200-day moving average can act as a simple “radar”.
- Watch 52-week highs/lows for momentum or risk shifts.
- Use strategy notes so alert emails instantly remind you why you track this asset.
Note: This is not investment advice—just common tracking angles for organizing your watchlist.
FAQ: Alerts & strategy
How do I set an alert for this asset?
Sign in, add the asset to your watchlist, then create price or trend alerts. Wavealert notifies you by email when your conditions are met.
What is the 200-day moving average?
The 200-day moving average is a long-term trend indicator. Many use it to spot trend shifts or stability—and set alerts around it. Learn more about the 200-day line
What is a delta alert?
A delta alert doesn’t watch a single target price; it monitors the strongest positive/negative move within a time window—useful for spotting volatility quickly. Delta alert explained
More features: Price alerts · Notes · News analysis
Track this asset in your portfolio
Create alerts, track performance, and get notified about price movements.
Why Wavealert?
Get notified when prices reach your targets or move significantly.
Track 50/200 day moving averages and identify trends.
See what alerts other investors are watching.